Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding

Status Completed

Clinical Trial Summary

This is a study to learn more about a drug called Tranexamic acid (TA), otherwise known as Lysteda, and whether or not this drug can decrease menstrual blood loss in young women and lead to an increase in the quality of life.

Menorrhagia in young women with bleeding disorders is typically treated with a combination of treatments including hormonal contraceptives. However, there are barriers to hormonal contraception use in younger adolescents.

Tranexamic acid is taken orally during the first 5 days of menstrual bleeding.

The purposes of this study include:

To test the safety and efficacy of Lysteda in adolescent females. To learn how well Lysteda works in decreasing menstrual blood loss. To see if parents and children participating in this study think the drug is improving their quality of life.

Lysteda has been approved by the Food and Drug Administration for use in patients > than 18 years of age but not for younger patients.

Clinical Trial Description

This is a multi-center (5 sites) open-label, single-arm, efficacy study of Lysteda in the treatment of adolescent females (10-19 years of age) with heavy menstrual bleeding (HMB). Each subject will receive oral Lysteda 1.3 grams three times daily during the first five days of menses. Subjects will be monitored over the course of four menstrual cycles (1 pre-treatment cycle and 3 treatment cycles). During all cycles, assessments of menstrual bleeding will be performed using the Menorrhagia Impact Questionnaire (MIQ) and Pictorial Blood Assessment Chart (PBAC).

The study will begin as a currently funded pilot study to assess the efficacy of Lysteda in 32 patients followed to study completion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01846507
Study type	Interventional
Source	Nationwide Children's Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	April 2013
Completion date	November 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02934789` - Effectiveness of Truclear on Patient Quality of Life	N/A
Completed	`NCT02925494` - An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Recruiting	`NCT04959396` - IUB SEAD RED (Revolutionary Endometrial Ablation Device Study	N/A
Active, not recruiting	`NCT04778072` - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects	N/A
Terminated	`NCT05026502` - A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
Recruiting	`NCT06064851` - Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Von Willebrand Disease Patients	N/A
Terminated	`NCT04132349` - Ulipristal Acetate in Symptomatic Uterine Fibroid	Phase 4
Completed	`NCT00386308` - Efficacy and Safety Study of XP12B in Women With Menorrhagia	Phase 3
Completed	`NCT03412890` - LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Active, not recruiting	`NCT04477837` - Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
Completed	`NCT05176496` - A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment
Completed	`NCT01431326` - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed	`NCT00401193` - Efficacy and Safety of XP12B in Women With Menorrhagia	Phase 3
Completed	`NCT03317795` - Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids	Phase 4
Completed	`NCT02943655` - Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause	Phase 3
Completed	`NCT03070951` - Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Recruiting	`NCT05685199` - Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
Completed	`NCT05406960` - Therapeutic Effect of Herbal Infusion on Menometrorrhagia	N/A
Not yet recruiting	`NCT05079815` - Heavy Menstrual Bleeding and Iron Deficiency Anemia
Active, not recruiting	`NCT02449304` - Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device	Phase 4